ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker
2021 · Signal Transduction and Targeted Therapy · 73 citations
https://doi.org/10.1038/s41392-021-00740-y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
48
Papers
1.1K
Citations
15
h-index
18
i10-index
Guifeng Wang is an academic researcher from Suzuka University of Medical Science. The author has contributed to research in topics: Hepatitis C virus research & Hepatitis B Virus Studies & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 15, co-authored 41 publications.
ORCID: 0000-0003-0716-0974Click to start Chat